Selegiline (orally disintegrating)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Selegiline (orally disintegrating), covering 2014-10-31 to 2014-10-31. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy of Orally Disintegrating Selegiline in Parkinson's Patients Experiencing Adverse Effects With Dopamine Agonists [Phase 4]